Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Beier

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Arthritis and Rheumatism|July 27, 2012
Time-series transcriptional profiling yields new perspectives on susceptibility to murine osteoarthritisBlandine Poulet, Veronica Ulici, Timothy C Stone, et al.
The American Journal of Pathology|February 5, 2013
Adult cartilage-specific peroxisome proliferator-activated receptor gamma knockout mice exhibit the spontaneous osteoarthritis phenotypeFaezeh Vasheghani, Roxana Monemdjou, Hassan Fahmi, et al.
Connective Tissue Research|March 31, 2016
The first international workshop on the epigenetics of osteoarthritisIngrid M Meulenbelt, Nidhi Bhutani, Wouter den Hollander, et al.
Japanese Journal of Clinical Oncology|March 13, 2013
Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trialTakayuki Yoshino, Yasuhisa Hasegawa, Shunji Takahashi, et al.
Journal of Cancer Research and Clinical Oncology|July 12, 2011
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trialCharles Butts, Andrew Maksymiuk, Glenwood Goss, et al.
Arthritis and Rheumatism|December 2, 2011
Association of cartilage-specific deletion of peroxisome proliferator-activated receptor γ with abnormal endochondral ossification and impaired cartilage growth and development in a murine modelRoxana Monemdjou, Faezeh Vasheghani, Hassan Fahmi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 11, 2008
F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-beta activationMukundan G Attur, Glyn D Palmer, Hayf E Al-Mussawir, et al.
Japanese Journal of Clinical Oncology|March 13, 2013
Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neckSusumu Okano, Takayuki Yoshino, Masato Fujii, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancerEric Van Cutsem, Heinz-Josef Lenz, Claus-Henning Köhne, et al.
Arthritis Research & Therapy|November 17, 2021
Expansion of myeloid-derived suppressor cells contributes to metabolic osteoarthritis through subchondral bone remodelingLixia Zhang, Cameron L Kirkwood, Jiho Sohn, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Arthritis and Rheumatism|July 27, 2012
Time-series transcriptional profiling yields new perspectives on susceptibility to murine osteoarthritisBlandine Poulet, Veronica Ulici, Timothy C Stone, et al.
The American Journal of Pathology|February 5, 2013
Adult cartilage-specific peroxisome proliferator-activated receptor gamma knockout mice exhibit the spontaneous osteoarthritis phenotypeFaezeh Vasheghani, Roxana Monemdjou, Hassan Fahmi, et al.
Connective Tissue Research|March 31, 2016
The first international workshop on the epigenetics of osteoarthritisIngrid M Meulenbelt, Nidhi Bhutani, Wouter den Hollander, et al.
Japanese Journal of Clinical Oncology|March 13, 2013
Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trialTakayuki Yoshino, Yasuhisa Hasegawa, Shunji Takahashi, et al.
Journal of Cancer Research and Clinical Oncology|July 12, 2011
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trialCharles Butts, Andrew Maksymiuk, Glenwood Goss, et al.
Arthritis and Rheumatism|December 2, 2011
Association of cartilage-specific deletion of peroxisome proliferator-activated receptor γ with abnormal endochondral ossification and impaired cartilage growth and development in a murine modelRoxana Monemdjou, Faezeh Vasheghani, Hassan Fahmi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 11, 2008
F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-beta activationMukundan G Attur, Glyn D Palmer, Hayf E Al-Mussawir, et al.
Japanese Journal of Clinical Oncology|March 13, 2013
Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neckSusumu Okano, Takayuki Yoshino, Masato Fujii, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancerEric Van Cutsem, Heinz-Josef Lenz, Claus-Henning Köhne, et al.
Arthritis Research & Therapy|November 17, 2021
Expansion of myeloid-derived suppressor cells contributes to metabolic osteoarthritis through subchondral bone remodelingLixia Zhang, Cameron L Kirkwood, Jiho Sohn, et al.
Pageof 15